| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.2M | — | +123.0% |
| R&D Expense | $20.0M | — | +26.3% |
| SG&A Expense | $5.9M | — | +58.2% |
| Operating Income | -$22.7M | — | -25.2% |
| Net Income | -$18.3M | — | -22.3% |
| EPS (Basic) | -$0.38 | — | +98.0% |
| EPS (Diluted) | -$0.38 | — | +98.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $371.6M | +883.6% | +538.0% |
| Current Assets | $543.9M | +136.2% | — |
| Total Assets | $576.8M | +117.8% | — |
| Current Liabilities | $27.9M | -10.6% | — |
| Total Liabilities | $70.7M | -8.9% | — |
| Stockholders' Equity | $506.1M | +446.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$24.2M | — | -38.7% |
| Capital Expenditures | $1.9M | — | -2.1% |
| Investing Cash Flow | $20.5M | — | -47.4% |
| Financing Cash Flow | $337.5M | — | — |
| Free Cash Flow | -$26.1M | — | -34.7% |
| +598.3% |